J Christian Virchow
Overview
Explore the profile of J Christian Virchow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1796
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lommatzsch M, Virchow J
Lancet Respir Med
. 2024 Nov;
13(1):2-3.
PMID: 39549711
No abstract available.
2.
3.
Wechsler M, Brusselle G, Virchow J, Bourdin A, Kostikas K, Llanos J, et al.
Eur Respir J
. 2024 Sep;
64(6).
PMID: 39326921
Background: In asthma, clinical response is characterised by disease improvement with treatment, whereas clinical remission is characterised by long-term disease stabilisation with or without ongoing treatment. The proportions of patients...
4.
Bratke K, Weise M, Stoll P, Virchow J, Lommatzsch M
Chest
. 2024 Mar;
166(4):793-801.
PMID: 38548099
Background: Microscopy is currently the gold standard to differentiate BAL fluid (BALF) leukocytes. However, local expertise for microscopic BALF leukocyte differentiation is often unavailable in clinical practice. Research Question: Can...
5.
Virchow J, Pfaar O, Lommatzsch M
Allergol Select
. 2024 Jan;
8:6-11.
PMID: 38249819
Remission is the goal of modern asthma treatment. Allergen immunotherapy (AIT) is an essential component in the armamentarium of personalized asthma therapy. Subcutaneous AIT (SCIT) or sublingual AIT (SLIT) offer...
6.
Lommatzsch M, Buhl R, Canonica G, Ribas C, Nagase H, Brusselle G, et al.
Lancet Respir Med
. 2023 Dec;
12(2):96-99.
PMID: 38071999
No abstract available.
7.
Response to Various Biologics in Patients with Both Asthma and Chronic Obstructive Pulmonary Disease
Lommatzsch M, Mohme S, Stoll P, Virchow J
Respiration
. 2023 Nov;
102(12):986-990.
PMID: 37984349
Introduction: Patients can have features of both chronic obstructive pulmonary disease (COPD) and asthma. However, there is still no consensus how to precisely define this patient population. In addition, there...
8.
Singh D, Papi A, Brusselle G, Virchow J, Canonica G, Topole E, et al.
ERJ Open Res
. 2023 May;
9(3).
PMID: 37228265
https://bit.ly/3TIYClX.
9.
Lommatzsch M, Dost M, Jaishankar N, Weise M, Stoll P, Virchow J, et al.
Allergy
. 2023 Mar;
78(7):2055-2057.
PMID: 36883436
No abstract available.
10.
Bourdin A, Virchow J, Papi A, Lugogo N, Bardin P, Antila M, et al.
Respir Med
. 2022 Sep;
202:106938.
PMID: 36087550
Background And Objective: Dupilumab blocks the shared receptor component for interleukin (IL)-4/IL-13, key and central drivers of type 2 inflammation in multiple diseases. In phase 3 QUEST (NCT02414854), add-on dupilumab...